These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22051925)

  • 1. Memantine for posttraumatic stress disorder in an older veteran.
    Chopra MP; Trevino KM; Kowall NW
    J Clin Psychopharmacol; 2011 Dec; 31(6):787-8. PubMed ID: 22051925
    [No Abstract]   [Full Text] [Related]  

  • 2. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
    Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA
    J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine for treatment-resistant OCD.
    Poyurovsky M; Weizman R; Weizman A; Koran L
    Am J Psychiatry; 2005 Nov; 162(11):2191-2. PubMed ID: 16263867
    [No Abstract]   [Full Text] [Related]  

  • 4. Memantine Augmentation in a Down's Syndrome Adolescent with Treatment- Resistant Obsessive-Compulsive Disorder.
    Pekrul SR; Fitzgerald KD
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):593-5. PubMed ID: 26258664
    [No Abstract]   [Full Text] [Related]  

  • 5. Memantine augmentation for refractory obsessive-compulsive disorder.
    Pasquini M; Biondi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1173-5. PubMed ID: 16730870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
    Kishi T; Matsuda Y; Iwata N
    J Alzheimers Dis; 2018; 64(1):43-48. PubMed ID: 29865079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).
    Haghighi M; Jahangard L; Mohammad-Beigi H; Bajoghli H; Hafezian H; Rahimi A; Afshar H; Holsboer-Trachsler E; Brand S
    Psychopharmacology (Berl); 2013 Aug; 228(4):633-40. PubMed ID: 23525525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
    Aboujaoude E; Barry JJ; Gamel N
    J Clin Psychopharmacol; 2009 Feb; 29(1):51-5. PubMed ID: 19142108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
    Bernhardt EB; Walsh KH; Posey DJ; McDougle CJ
    J Clin Psychopharmacol; 2011 Oct; 31(5):673-5. PubMed ID: 21881459
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
    Mukai Y; Two A; Jean-Baptiste M
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22687661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.
    Bandelow B; Sher L; Bunevicius R; Hollander E; Kasper S; Zohar J; Möller HJ; ;
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):77-84. PubMed ID: 22540422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.
    Goddard AW; Shekhar A; Whiteman AF; McDougle CJ
    Drug Discov Today; 2008 Apr; 13(7-8):325-32. PubMed ID: 18405845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder.
    Petrikis P; Andreou C; Bozikas VP; Karavatos A
    Can J Psychiatry; 2004 Aug; 49(8):572-3. PubMed ID: 15453108
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
    Bystritsky A; Ackerman DL; Rosen RM; Vapnik T; Gorbis E; Maidment KM; Saxena S
    J Clin Psychiatry; 2004 Apr; 65(4):565-8. PubMed ID: 15119922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
    Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
    J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.